FDA clears Stereotaxis robotic system | Heart patient sues Abbott | 3D echo in the congenital OR | New-onset AFib after CABG

GenesisX represents the company’s most accessible robotic system to date. It requires no room shielding or structural anchoring, for example, and the size has been significantly reduced.

The patient's Trifecta GT heart valve had to be replaced after just six years, an experience he says resulted in "permanent injuries." Abbott pulled the devices off the U.S. market in 2023 due to a known risk of structural valve deterioration. 

TAVR may get more attention, but the Ross procedure has also gained significant momentum in recent years. Ismail El-Hamamsy, MD, PhD, detailed his own team's success with the complex procedure.

Cardiologists, cardiac surgeons and cardiology APPs all earned more in 2024 than 2023, according to a new survey. Compensation in private practices continues to be much lower than it is integrated practices. 

Robert H. Bartlett, MD, was a pioneer surgeon who helped develop the world's first ECMO technology. He died at the age of 86 following a long illness. 

The new patch is implanted through a tiny incision and held in place with a biocompatible adhesive. It then helps the heart recover over time, replacing dead tissue that would typically never be able to regenerate. 

Tulyp Medical, a French medtech startup, has emerged from stealth focused on securing FDA clearance for a patented perfusion device.

Nee Khoo, MBChB, director of the echocardiography lab at Canada's Stollery Children’s Hospital, explains the rapid adoption of pediatric 3D transesophageal echo.

The study's authors questioned if these patients should even be given oral anticoagulation as currently recommended.

The company, founded in 1966, has been providing supplies to cardiac surgery suites and cath labs for decades.